ArticleOncotarget2015

Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer.

Joshua A McCarroll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.